Archives: Agenda

With a disproportionately large number of patients willing to participate in global studies, Canada’s world-class researchers and diverse patient population, trial cost efficiency, robust health authority with reliable process times, consistent data quality, and national therapeutic expertise in oncology make it an attractive country for enrollment to your global clinical trial program.

This presentation explores how to succeed with your oncology trial in Canada with insights on:

• The Perception Gap
• How Sponsors Receive: Predictability. Speed. Quality. Partner Accountability
• Competitive Structural Advantages
• Real-World Global Trial Examples
• What to Expect in a Partner for the Region

• Tackling challenges in cell and gene therapy studies to reduce timelines and ensure quality
• Overviewing innovation and available technology to accelerate and streamline study processes
• Partnering with vendors effectively to ensure specialized patient selection to enhance study start-up

• Keeping compliant with evolving global, regional, and local regulation to minimize timelines and avoid costly delays
• Overviewing new regulation and assessing the impact on conducting oncology clinical trials
• Ensuring vendor oversight to ensure regulatory compliance for smooth running of oncology clinical trials
• Considering Project Optimus early in development programs to keep in line with regulatory demands

How strategic collaboration can accelerate innovation:

• Moving from transactional execution to consultative partnership
• How CROs can become strategic problem solvers, not just service providers
• Building trust transparency and shared accountability